HESI Workshop – Cardiac Safety and Drug Development
- Start Date/Time :
- End Date/Time :
- Location : Hybrid Meeting, FDA White Oak, Silver Spring, MD, USA
The HESI Cardiac Safety Committee is hosting a 2-day workshop focused on Cardiac Safety and Drug Development. Virtual and In-person options are available.
Day 1: May 7, 2024; 8:30 am – 5:00 pm ET
Day 1 title: Workshop on Validating and Using Cardiac NAMs for Toxicity Screening and Drug Development
Day 1: Final Agenda
Day 2: May 8, 2024; 8:30 am – 5:00 pm ET
Day 2 title: Advances in Cardiac Safety Assessments Workshop
Day 2: Final Agenda
Location: Hybrid Virtual Option and In-Person at FDA White Oak, Silver Spring, MD
Registration Closed. Contact for more information: Jennifer Pierson (jpierson@hesiglobal.org)